5 results match your criteria: "Deutschland. arndt.vanophoven@marienhospital-herne.de.[Affiliation]"
[Therapeutic value of neuromodulation in women].
Urologie
February 2023
Abteilung für Neuro-Urologie, Marien Hospital Herne, Universitätsklinikum der Ruhr-Universität Bochum, Hölkeskampring 40, 44625, Herne, Deutschland.
Background: Neuromodulative treatment for the treatment of overactive bladder has been used in clinical practice since its introduction in the early 1980s.
Objectives: Description and update of the various neuromodulative techniques (tibial nerve stimulation, sacral and pudendal neuromodulation), presentation of their effectiveness and safety, and evaluation of their evidence for clinical practice.
Materials And Methods: Literature search in PubMed and Embase, inclusion of studies according to the following criteria: evidence level, timeliness, length of follow-up and number of female patients according to the author's preference.
[Sacral neuromodulation for refractory overactive bladder].
Urologe A
November 2018
Abteilung für Neuro-Urologie, Marien Hospital Herne, Universitätsklinikum der Ruhr-Universität Bochum, Hölkeskampring 40, 44625, Herne, Deutschland.
Article Synopsis
- Sacral neuromodulation (SNM) is a minimally invasive treatment for overactive bladder (OAB) and other pelvic disorders like urinary retention and fecal incontinence.
- A pacemaker device is implanted in the upper buttocks, sending electrical pulses to the sacral nerves to help regulate nerve signals from pelvic organs.
- The article reviews important aspects of SNM, including its indications, contraindications, how it works, implantation process, effectiveness, and potential complications for patients with OAB that doesn't respond to other treatments.
[Neuro-urology].
Urologe A
February 2012
Schwerpunkt für Neuro-Urologie, Stiftung Katholisches Krankenhaus, Marienhospital Herne, Klinikum der Ruhr-Universität, Widumer Straße 8, 44627 Herne, Deutschland.
[The future of invasive neuromodulation: new techniques and expanded indications].
Urologe A
February 2012
Schwerpunkt für Neuro-Urologie, Stiftung Katholisches Krankenhaus, Marienhospital Herne, Klinikum der Ruhr-Universität Bochum, Widumer Straße 8, 44627 Herne, Deutschland.
Due to the increasing popularity of neuromodulation, the number of indications and patient groups to which this technique is offered is also increasing. We evaluated the currently available data concerning neuromodulation in geriatric patients, children and patients with spinal cord injury and potential alternatives regarding neural targets and implantation techniques.The evidence of the use of neuromodulation in these patient groups is low.
View Article and Find Full Text PDF[From end-organ disease to a classifiable bladder pain syndrome: paradigm shift in the understanding of urological pain syndromes exemplified by the condition currently called interstitial cystitis].
Urologe A
February 2009
Schwerpunkt für Neurourologie, Universitätsklinikum Marienhospital Herne, Ruhr-Universität Bochum, Widumerstrasse 8, 44627, Herne, Deutschland.
Growing clinical and scientific data imply that the condition currently called interstitial cystitis is not just a mere bladder end-organ disease but that the symptoms perceived to be related to the bladder are rather one aspect of a complex pelvic pain syndrome. The term bladder pain syndrome/interstitial cystitis (BPS/IC) suggested by the European Society for the Study of IC/PBS (ESSIC) for this condition is currently the only one strictly consistent with the taxonomy guidelines of the European Association of Urology and the International Association for the Study of Pain. BPS would be diagnosed on the basis of chronic pelvic pain, pressure, or discomfort perceived to be related to the urinary bladder, accompanied by at least one other urinary symptom such as persistent urge to void or urinary frequency.
View Article and Find Full Text PDF